Noninvasive prenatal testing: limitations and unanswered questions
- 1 April 2014
- journal article
- Published by Elsevier in Genetics in Medicine
- Vol. 16 (4) , 281-285
- https://doi.org/10.1038/gim.2013.126
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Fetal aneuploidy screening by maternal plasma DNA sequencing: ‘False positive’ due to confined placental mosaicismPrenatal Diagnosis, 2012
- Genome-Wide Fetal Aneuploidy Detection by Maternal Plasma DNA SequencingObstetrics & Gynecology, 2012
- DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative studyGenetics in Medicine, 2012
- Selective analysis of cell‐free DNA in maternal blood for evaluation of fetal trisomyPrenatal Diagnosis, 2012
- Noninvasive Prenatal Diagnosis of Fetal Trisomy 18 and Trisomy 13 by Maternal Plasma DNA SequencingPLOS ONE, 2011
- Aneuploidy screening: a position statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, January 2011Prenatal Diagnosis, 2011
- Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity studyBMJ, 2011
- Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal bloodProceedings of the National Academy of Sciences, 2008
- Reevaluating confined placental mosaicismAmerican Journal of Medical Genetics Part A, 2004
- Confined placental mosaicism in term placentae: Analysis of 125 casesPrenatal Diagnosis, 1995